Thermopylae Holdings Ltd., 10% Owner at AbCellera Biologics Inc. (ABCL), bought 170,204 shares at $10.10 ($1.7M) on 2022-12-16, disclosed to the SEC on 2022-12-20.
Open-market purchase of $1.7M ABCL by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.10 | 85,102 | $860K | 50.0% |
| 2 | $10.10 | 85,102 | $860K | 50.0% |
| Total | $10.10 avg | 170,204 | $1.7M | 100% |
| Filing → |
| ABCL | BUY | 2025-03-11 | $1.5M | — | Filing → |
| ABCL | BUY | 2024-08-29 | $1.5M | — | Filing → |
| ABCL | BUY | 2023-05-26 | $2.0M | — | Filing → |